Next Article in Journal
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
Next Article in Special Issue
High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
Previous Article in Journal
Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer
Previous Article in Special Issue
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
 
 
Article

Article Versions Notes

Cancers 2021, 13(15), 3861; https://doi.org/10.3390/cancers13153861
Action Date Notes Link
article xml file uploaded 31 July 2021 10:31 CEST Original file -
article xml uploaded. 31 July 2021 10:31 CEST Update https://www.mdpi.com/2072-6694/13/15/3861/xml
article pdf uploaded. 31 July 2021 10:31 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3861/pdf
article supplementary file uploaded. 31 July 2021 10:31 CEST - https://www.mdpi.com/2072-6694/13/15/3861#supplementary
article html file updated 31 July 2021 10:32 CEST Original file -
article html file updated 27 July 2022 07:36 CEST Update https://www.mdpi.com/2072-6694/13/15/3861/html
Back to TopTop